Provided by Tiger Fintech (Singapore) Pte. Ltd.

Artelo Biosciences, Inc.

1.01
-0.0300-2.88%
Pre-market: 1.050.0300+2.94%08:50 EDT
Volume:29.44K
Turnover:31.42K
Market Cap:3.26M
PE:-0.33
High:1.10
Open:1.04
Low:1.01
Close:1.04
Loading ...

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Yesterday

Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating ART26.12’s Effectiveness in Treating Psoriasis

GlobeNewswire
·
Yesterday

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Apr

New Strong Sell Stocks for March 6th

Zacks
·
06 Mar

Artelo Biosciences Reports 2024 Financial Results and Clinical Progress

TIPRANKS
·
06 Mar

Artelo Biosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
03 Mar

Artelo Biosciences FY 2024 GAAP EPS $(3.05) Misses $(2.44) Estimate

Benzinga
·
03 Mar

Artelo Biosciences FY Net Income USD -9.8 Million

THOMSON REUTERS
·
03 Mar

Press Release: Artelo Biosciences Provides Business Update and Reports Fiscal 2024 Year-End Financial Results

Dow Jones
·
03 Mar

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
27 Feb

Artelo Biosciences announces new data on ART12.11

TIPRANKS
·
14 Feb

Artelo Biosciences Announces New Data on Art12.11 Tablets Showing Improved Pharmacokinetics to Epidiolex®

THOMSON REUTERS
·
14 Feb

Alpha Real Trust Acquires Five Crematoria In England For £34.2m

T-Reuters
·
21 Jan

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
14 Jan

Artelo Biosciences completes first cohort in Phase 1 study of ART26.12

TIPRANKS
·
13 Jan

Artelo Biosciences Announces Successful Completion of First Cohort in a Phase 1 Study of Art26.12

THOMSON REUTERS
·
13 Jan

Artelo Biosciences Inc - Initial Safety and Pharmacokinetic Data Expected First Half 2025

THOMSON REUTERS
·
13 Jan

Artelo Biosciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
10 Dec 2024

Artelo Biosciences Price Target Maintained With a $5.00/Share by HC Wainwright & Co.

Dow Jones
·
09 Dec 2024